PRiME-Unity Health Toronto Clinical Catalyst Program Guidelines
General Info
Award Value: $45,000 for a Postdoctoral or Clinical Fellow
Award Duration: 1 year
Number of Awards: Funding is available for 2 awards
Focus Areas: All disease areas will be considered. Primary focus is on clinical applications of basic research discoveries.
DEADLINE EXTENDED: February 6th, 2023 11:59PM EST
Eligibility
-
The applicant must be either a full-time Postdoctoral Fellow or Clinical Fellow (with less than 4 years PDF training at the time of application).
-
The proposed project must be a collaboration between two or more principal investigator (PIs), at least one that is based at the University of Toronto and is a member of PRiME, and one that is based at Unity Health Toronto.
-
If a UofT-based investigator is interested in this program, but is not yet a member of PRiME, please email prime.initiative@utoronto.ca.
-
PRiME funding is meant to create a unique opportunity and may be used in conjunction with other funding, but cannot duplicate an existing funding source for the project.
-
The Postdoctoral Fellow or Clinical Fellow cannot be funded by another Research Fellowship during the same period.
-
The proposed project cannot be already funded by a PRiME Fellowship Award at the time of the application or award.
How to Apply
Applications will outline the applicant and the collaboration’s outstanding potential of productivity working on cutting-edge, high-risk ideas. The application package must include the following components:
-
PRiME Clinical Catalyst Award application form
-
Project Lay Summary (maximum 250 words): Provide a summary in non-specialist language of the proposal, highlighting specific project objectives and deliverables, and describing how the research is globally competitive and translatable to women’s health.
-
Proposal (≦ 2 pages including references + up to one additional page for supporting tables & figures): Provide an overview of the proposed research, including background, methods and specific project deliverables. A short summary of the translational impact of the research should also be included specifying disease indication and/or patient population(s) expected to benefit most. If multiple indications are possible, these should all be mentioned.
-
Short Applicant Curriculum Vitae (maximum 4 pages).
-
Letter(s) of Support (*maximum 1 page per Supervisor; supervisors can co-sign a single letter of support with a maximum of 2 pages).
Application Forms and Guidelines
Important Dates
Competition Announced: November 30th, 2022
Full Applications Due: February 6th, 2023
Application Review: February 2023
Notice of Award: Mid-March 2023
Public Announcement and fellowship start: April 1st, 2023